Myriad Genetics Inc (MYGN)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -127,300 -116,000 -155,200 -234,600 -263,300 -274,400 -248,200 -146,200 -112,000 -77,300 -17,600 -8,200 -27,200 -63,800 -103,600 -154,300 -230,000 -194,100 -199,500 -148,300
Total stockholders’ equity US$ in thousands 701,100 731,700 740,500 760,000 783,200 683,400 735,200 835,200 885,800 916,600 947,400 950,100 967,800 968,600 902,500 875,200 879,900 909,300 918,200 967,200
ROE -18.16% -15.85% -20.96% -30.87% -33.62% -40.15% -33.76% -17.50% -12.64% -8.43% -1.86% -0.86% -2.81% -6.59% -11.48% -17.63% -26.14% -21.35% -21.73% -15.33%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-127,300K ÷ $701,100K
= -18.16%

Myriad Genetics Inc's return on equity (ROE) has exhibited a declining trend over the analyzed period, starting from negative values and gradually deteriorating further. The ROE was notably negative in the initial periods, ranging from -15.33% to -26.14%. However, there was a slight improvement noted in the subsequent quarters, with ROE values ranging from -2.81% to -11.48%.

Despite this temporary improvement, the company's ROE once again started decreasing from March 31, 2022, onwards. The most significant drop in ROE was observed in June 30, 2023, where it reached -33.76%, indicating a sharp decline in the profitability derived from shareholders' equity. This negative trend continued into the following quarters, with ROE values ranging from -18.16% to -40.15% by December 31, 2024.

Overall, the consistent negative ROE figures signify that Myriad Genetics Inc has been struggling to generate sustainable returns on its equity capital, which may raise concerns among investors and stakeholders regarding the firm's financial health and operational efficiency.